Cleared Traditional

K943571 - MULTI-LEVEL CONTROL FOR FIBRIN DEGRADAT...

K943571 is the FDA 510(k) clearance for MULTI-LEVEL CONTROL FOR FIBRIN DEGRADAT... by More Diagnostics. It is a Class 2 Hematology device (product code DAP) cleared through the Traditional 510(k) pathway after a 331-day FDA review.

K943571 · More Diagnostics · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1995
Decision
331d
Days
Class 2
Risk

K943571 is an FDA 510(k) clearance for the MULTI-LEVEL CONTROL FOR FIBRIN DEGRADATION PRODUCTS. Classified as Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control (product code DAP), Class II - Special Controls.

Submitted by More Diagnostics (Los Osos, US). The FDA issued a Cleared decision on June 15, 1995 after a review of 331 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7320 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all More Diagnostics devices

Submission Details

510(k) Number K943571 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 19, 1994
Decision Date June 15, 1995
Days to Decision 331 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
218d slower than avg
Panel avg: 113d · This submission: 331d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DAP Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - DAP Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control

All 44
Devices cleared under the same product code (DAP) and FDA review panel - the closest regulatory comparables to K943571.
IL TEST D-DIMER
K972696 · Instrumentation Laboratory CO · Nov 1997
STA-LIATEST D-DI TEST KIT
K964728 · American Bioproducts Co. · Jun 1997
STA D-DI CALIBRATOR KIT
K964718 · American Bioproducts Co. · May 1997
AURATEK FDP
K943787 · Organon Teknika Corp. · Sep 1994
FIBRINOSTIKA TDP MICROELISA SYSTEM
K915698 · Organon Teknika Corp. · Aug 1992
FDP PLASMA TEST KIT
K920943 · American Bioproducts Co. · Jul 1992